Cytokinetics’ CK-274 Appears To Upstage BMS’s Newly Acquired Mavacamten

Phase III Trial To Start By Year’s End

 
• By Mandy Jackson
  
Cardiology vector illustration; cardiomyopathy
Echocardiograms at multiple timepoints showed efficacy in both CK-274 cohorts • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D